Biogen Idec Ltd - 검색 결과

보스니아 헤르체고비나 - 크로아티아어 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

tecfidera 240 mg/1 kapsula gastrorezistentna kapsula, tvrda

medis international d.o.o. sarajevo - dimetil fumarat - gastrorezistentna kapsula, tvrda - 240 mg/1 kapsula - 1 gastrorezistentna kapsula, tvrda sadrži: 240 mg dimetil fumarata

유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

onbevzi

samsung bioepis nl b.v. - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - onbevzi in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. onbevzi in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer. za daljnje informacije o stanju čovjeka epidermalnog faktora rasta receptora 2 (her2), molimo pogledajte odjeljak 5. onbevzi in combination with capecitabine is indicated for first-line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with onbevzi in combination with capecitabine. dodatne informacije o statusu her2 potražite u odjeljku 5. onbevzi, in addition to platinum-based chemotherapy, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-small cell lung cancer other than predominantly squamous cell histology. onbevzi, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. onbevzi in combination with interferon alfa-2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. onbevzi, in combination with carboplatin and paclitaxel is indicated for the front-line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. onbevzi, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. onbevzi, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. onbevzi, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

크로아티아 - 크로아티아어 - HALMED (Agencija za lijekove i medicinske proizvode)

compassia 10 mg filmom obložene tablete

mylan hrvatska d.o.o., koranska 2, zagreb, hrvatska - escitalopramum - filmom obložena tableta - 10 mg - urbroj: jedna filmom obložena tableta sadrži 10 mg escitaloprama u obliku escitalopramoksalata

크로아티아 - 크로아티아어 - HALMED (Agencija za lijekove i medicinske proizvode)

dopamin admeda 200 mg/10 ml koncentrat za otopinu za infuziju

medicuspharma d.o.o., rokov perivoj 6/a, zagreb - dopaminklorid - koncentrat za otopinu za infuziju - 200 mg/10 ml - urbroj: 1 ampula koncentrata za otopinu za infuziju sadrži 200 mg dopaminklorida; 1 ml koncentrata za otopinu za infuziju sadrži 20 mg dopaminklorida

크로아티아 - 크로아티아어 - HALMED (Agencija za lijekove i medicinske proizvode)

dopamin admeda 50 mg/5 ml koncentrat za otopinu za infuziju

medicuspharma d.o.o., rokov perivoj 6/a, zagreb, hrvatska - dopaminklorid - koncentrat za otopinu za infuziju - 50 mg/5 ml - urbroj: 1 ampula koncentrata za otopinu za infuziju sadrži 50 mg dopaminklorida 1 ml koncentrata za otopinu za infuziju sadrži 10 mg dopaminklorid

zepira 5 mg/1 tableta film tableta

alkaloid d.o.o. sarajevo, isevića sokak 6, sarajevo - эсциталопрам - film tableta - 5 mg/1 tableta - 1 film tableta sadrži: 5 mg escitalopram (u obliku escitalopramoksalata)

zepira 10 mg/1 tableta film tableta

alkaloid d.o.o. sarajevo, isevića sokak 6, sarajevo - эсциталопрам - film tableta - 10 mg/1 tableta - 1 film tableta sadrži: 10 mg escitalopram (u obliku escitalopramoksalata)

zepira 15 mg/1 tableta film tableta

alkaloid d.o.o. sarajevo, isevića sokak 6, sarajevo - эсциталопрам - film tableta - 15 mg/1 tableta - 1 film tableta sadrži: 15 mg escitalopram (u obliku escitalopramoksalata)

zepira 20 mg/1 tableta film tableta

alkaloid d.o.o. sarajevo, isevića sokak 6, sarajevo - эсциталопрам - film tableta - 20 mg/1 tableta - 1 film tableta sadrži: 20 mg escitalopram (u obliku escitalopramoksalata)

citram 10 mg/1 tableta filmom obložena tableta

farmavita d.o.o. sarajevo - эсциталопрам - filmom obložena tableta - 10 mg/1 tableta - 1 filmom obložena tableta sadrži: 10 mg escitalopram (u obliku escitalopramoksalata)